PharmaKing: Clinical Trials

12 trials sponsored by PharmaKing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 6 Phase 2, 3 Phase 3, 2 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 33Completed 3
Phase 12Completed 2
Phase 41Completed 1

Follow PharmaKing: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis
Oltipraz, Placebos - Non-Alcoholic Fatty Liver Disease
Phase 3CompletedPharmaKing1462019-11-152022-10-06
Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis
N02RS1 1200mg, Placebo - Acute Bronchitis
Phase 2CompletedPharmaKing1082015-12-012016-03-30
Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
Placebo, PMK-S005 1, PMK-S005 2 - Peptic Ulcer
Phase 2CompletedPharmaKing882014-11-242018-01-23
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis
Oltipraz 1 (90mg), Placebo, Oltipraz 2 (120mg) - Non-alcholic Fatty Liver Disease
Phase 3CompletedPharmaKing2832014-02-012016-03-30
Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma
Montelukast, Montelukast sodium - Asthma and Allergic Rhinitis
Phase 1CompletedPharmaKing402013-11-012015-04-29
Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis
Combination of Broussonetia spp and Lonicera spp - Acute Exacerbation of Chronic Bronchitis
Phase 2CompletedPharmaKing1022013-11-012014-05-30
A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers
PMK-S005 - Gastritis, Gastric Ulcer
Phase 1CompletedPharmaKing372012-12-012014-05-30
To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease
Pennel, Legalon, Placebo - Chronic Liver Disease
Phase 4CompletedPharmaKing2622012-04-012015-01-27
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease
Placebo, Oltipraz - Non-alcoholic Fatty Liver Disease
Phase 2CompletedPharmaKing602011-05-012013-12-10
Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
Placebo /bid P.O, MG-1, MG-2 : MG1000mg, Placebo /bid P.O - Alcoholic Fatty Liver Disease, Alcoholic Hepatitis
Phase 2CompletedPharmaKing902010-11-012015-04-29
Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease
NISSEL, PENNEL - Chronic Liver Disease
Phase 3CompletedPharmaKing2201997-11-012011-07-13
Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease
PENNEL capsule, Placebo - Chronic Liver Disease
Phase 2CompletedPharmaKing881996-12-012011-07-13

Conditions studied

Non-alcoholic Fatty Liver Disease (2)  ·  Asthma (1)  ·  Bronchitis (1)  ·  Fatty Liver, Alcoholic (1)  ·  Gastritis (1)  ·  Hepatitis, Alcoholic (1)  ·  Peptic Ulcer (1)  ·  Rhinitis, Allergic (1)  ·  Stomach Ulcer (1)

Interventions

oltipraz (2)  ·  Lactose (1)  ·  PMK-S005 (1)  ·  Silymarin (1)  ·  metadoxine (1)  ·  montelukast (1)

Countries

South Korea (11)

Top investigators

Minho Lee, MD.PhD (2)  ·  Byeongguk Jang, MD.PhD (1)  ·  Byeonggwan Kim, MD.PhD (1)  ·  Changuk Kim, MD.PhD (1)  ·  Chun Kyun Lee, MD.PhD (1)  ·  Daewon Jun, MD.PhD (1)  ·  Doyeong Kim, MD.PhD (1)  ·  Gapjin Chun, MD.PhD (1)  ·  Huieon Kim, MD.PhD (1)  ·  Hyeongjun Kim, MD.PhD (1)  ·  Hyeonung Lee, MD.PhD (1)  ·  Jaeyeong Chang, MD.PhD (1)  ·  Jaeyeong Jung, MD.PhD (1)  ·  Jaeyun Jung, MD.PhD (1)  ·  Jihun Kim, MD.PhD (1)

Results publications

PMID 22943930, PMID 28225186